- Home
- BROG vs ACHV Comparison
BROG vs ACHV Comparison
Compare BROG & ACHV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BROG
- ACHV
- Stock Information
- Founded
- BROG 2019
- ACHV N/A
- Country
- BROG United Arab Emirates
- ACHV Canada
- Employees
- BROG N/A
- ACHV N/A
- Industry
- BROG Integrated oil Companies
- ACHV Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- BROG Energy
- ACHV Health Care
- Exchange
- BROG Nasdaq
- ACHV Nasdaq
- Market Cap
- BROG 143.6M
- ACHV 137.6M
- IPO Year
- BROG N/A
- ACHV N/A
- Fundamental
- Price
- BROG $1.38
- ACHV $3.69
- Analyst Decision
- BROG
- ACHV Strong Buy
- Analyst Count
- BROG 0
- ACHV 5
- Target Price
- BROG N/A
- ACHV $14.80
- AVG Volume (30 Days)
- BROG 17.4K
- ACHV 142.3K
- Earning Date
- BROG 02-15-2025
- ACHV 11-07-2024
- Dividend Yield
- BROG N/A
- ACHV N/A
- EPS Growth
- BROG N/A
- ACHV N/A
- EPS
- BROG N/A
- ACHV N/A
- Revenue
- BROG $105,695,648.00
- ACHV N/A
- Revenue This Year
- BROG N/A
- ACHV N/A
- Revenue Next Year
- BROG N/A
- ACHV N/A
- P/E Ratio
- BROG N/A
- ACHV N/A
- Revenue Growth
- BROG 29.62
- ACHV N/A
- 52 Week Low
- BROG $0.80
- ACHV $3.41
- 52 Week High
- BROG $6.66
- ACHV $5.59
- Technical
- Relative Strength Index (RSI)
- BROG 46.84
- ACHV 26.02
- Support Level
- BROG $1.26
- ACHV $4.07
- Resistance Level
- BROG $1.98
- ACHV $4.21
- Average True Range (ATR)
- BROG 0.16
- ACHV 0.22
- MACD
- BROG 0.01
- ACHV -0.06
- Stochastic Oscillator
- BROG 18.92
- ACHV 8.49
About BROG Brooge Energy Limited
Brooge Energy Ltd is an Oil Refinery & Storage Company in the United Arab Emirates. The company generates revenue from the leasing of storage capacity of tanks and other ancillary services.
About ACHV Achieve Life Sciences Inc.
Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.